Andrew Bradford
Concepts (390)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| E2F1 Transcription Factor | 12 | 2026 | 72 | 1.850 |
Why?
| | Endometrial Neoplasms | 7 | 2021 | 196 | 1.670 |
Why?
| | Follicle Stimulating Hormone | 14 | 2026 | 247 | 1.630 |
Why?
| | Luteinizing Hormone | 14 | 2026 | 187 | 1.480 |
Why?
| | Promoter Regions, Genetic | 19 | 2026 | 1263 | 1.110 |
Why?
| | Prolactin | 10 | 2022 | 92 | 1.030 |
Why?
| | Metabolic Syndrome | 5 | 2026 | 354 | 0.980 |
Why?
| | Hyperlipidemias | 3 | 2022 | 127 | 0.980 |
Why?
| | Hyperinsulinism | 3 | 2022 | 115 | 0.960 |
Why?
| | Leiomyoma | 3 | 2019 | 58 | 0.950 |
Why?
| | Obesity | 16 | 2024 | 3041 | 0.950 |
Why?
| | Uterine Neoplasms | 3 | 2019 | 96 | 0.910 |
Why?
| | Protein Kinase C-alpha | 3 | 2009 | 37 | 0.860 |
Why?
| | Gene Expression Regulation, Neoplastic | 12 | 2026 | 1487 | 0.830 |
Why?
| | E2F Transcription Factors | 6 | 2026 | 79 | 0.810 |
Why?
| | Pituitary Gland | 7 | 2021 | 151 | 0.790 |
Why?
| | Human Growth Hormone | 1 | 2022 | 46 | 0.720 |
Why?
| | Proto-Oncogene Proteins | 9 | 2015 | 626 | 0.710 |
Why?
| | Genes, Tumor Suppressor | 6 | 2026 | 92 | 0.700 |
Why?
| | Diet, High-Fat | 4 | 2026 | 260 | 0.700 |
Why?
| | Gene Expression Profiling | 6 | 2019 | 1794 | 0.690 |
Why?
| | Corpus Luteum | 3 | 2016 | 20 | 0.690 |
Why?
| | Soybean Oil | 1 | 2021 | 15 | 0.690 |
Why?
| | Protein Kinase C-delta | 5 | 2009 | 47 | 0.680 |
Why?
| | Gene Products, tax | 3 | 2025 | 15 | 0.670 |
Why?
| | Human T-lymphotropic virus 1 | 3 | 2025 | 32 | 0.660 |
Why?
| | Cell Proliferation | 11 | 2026 | 2542 | 0.640 |
Why?
| | Phospholipids | 2 | 2021 | 212 | 0.640 |
Why?
| | Leiomyosarcoma | 1 | 2019 | 29 | 0.610 |
Why?
| | Apoptosis | 12 | 2026 | 2519 | 0.540 |
Why?
| | Fibroblast Growth Factors | 4 | 2021 | 186 | 0.500 |
Why?
| | Insulin | 5 | 2022 | 2497 | 0.500 |
Why?
| | Transcriptional Activation | 5 | 2025 | 380 | 0.490 |
Why?
| | Gene Expression Regulation | 11 | 2023 | 2621 | 0.490 |
Why?
| | Signal Transduction | 12 | 2025 | 5214 | 0.470 |
Why?
| | High Fructose Corn Syrup | 1 | 2015 | 8 | 0.470 |
Why?
| | Granulosa Cells | 1 | 2015 | 33 | 0.460 |
Why?
| | Weight Gain | 2 | 2016 | 550 | 0.440 |
Why?
| | Proto-Oncogene Proteins c-ets | 8 | 2007 | 56 | 0.440 |
Why?
| | DEAD-box RNA Helicases | 2 | 2025 | 90 | 0.430 |
Why?
| | Fibroblast Growth Factor 2 | 3 | 2006 | 88 | 0.420 |
Why?
| | Cell Line, Tumor | 14 | 2026 | 3611 | 0.410 |
Why?
| | Dietary Fats | 1 | 2015 | 304 | 0.400 |
Why?
| | Adenocarcinoma | 3 | 2009 | 911 | 0.390 |
Why?
| | Transcription Factors | 8 | 2018 | 1754 | 0.380 |
Why?
| | MAP Kinase Signaling System | 3 | 2006 | 325 | 0.370 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1282 | 0.370 |
Why?
| | Retinoblastoma Protein | 4 | 2026 | 109 | 0.360 |
Why?
| | DNA-Binding Proteins | 8 | 2018 | 1524 | 0.360 |
Why?
| | MicroRNAs | 2 | 2015 | 698 | 0.350 |
Why?
| | Gonadotropins | 3 | 2023 | 40 | 0.350 |
Why?
| | Protein Kinase C | 2 | 2003 | 253 | 0.340 |
Why?
| | Aromatase Inhibitors | 3 | 2020 | 58 | 0.340 |
Why?
| | Cross-Over Studies | 3 | 2022 | 583 | 0.330 |
Why?
| | Fibroblast Growth Factor 4 | 3 | 2006 | 19 | 0.330 |
Why?
| | Homeodomain Proteins | 5 | 2012 | 523 | 0.320 |
Why?
| | Estradiol | 5 | 2023 | 525 | 0.310 |
Why?
| | Menstrual Cycle | 3 | 2026 | 139 | 0.310 |
Why?
| | Tumor Protein p73 | 2 | 2026 | 18 | 0.300 |
Why?
| | Female | 37 | 2026 | 77251 | 0.300 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 155 | 0.290 |
Why?
| | Hydrocortisone | 2 | 2022 | 311 | 0.270 |
Why?
| | Humans | 51 | 2026 | 143560 | 0.270 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2024 | 539 | 0.270 |
Why?
| | RNA, Messenger | 2 | 2015 | 2852 | 0.270 |
Why?
| | Cyclin-Dependent Kinases | 2 | 2026 | 147 | 0.250 |
Why?
| | Growth Hormone | 3 | 2022 | 99 | 0.240 |
Why?
| | Ovarian Neoplasms | 1 | 2012 | 586 | 0.240 |
Why?
| | Leukemia-Lymphoma, Adult T-Cell | 1 | 2025 | 17 | 0.240 |
Why?
| | Mouse Embryonic Stem Cells | 1 | 2026 | 40 | 0.240 |
Why?
| | HTLV-I Infections | 1 | 2025 | 28 | 0.240 |
Why?
| | Neoplasms | 4 | 2026 | 2804 | 0.240 |
Why?
| | Isoenzymes | 3 | 2003 | 299 | 0.230 |
Why?
| | Cytokines | 4 | 2024 | 2097 | 0.230 |
Why?
| | Weight Loss | 2 | 2024 | 811 | 0.220 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 651 | 0.220 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2024 | 25 | 0.210 |
Why?
| | Adipokines | 1 | 2024 | 53 | 0.210 |
Why?
| | Tumor Cells, Cultured | 5 | 2007 | 974 | 0.210 |
Why?
| | Phosphorylation | 5 | 2024 | 1781 | 0.200 |
Why?
| | Live Birth | 1 | 2024 | 73 | 0.200 |
Why?
| | Preconception Care | 1 | 2024 | 50 | 0.200 |
Why?
| | Estrone | 3 | 2026 | 40 | 0.200 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2016 | 127 | 0.200 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2003 | 55 | 0.200 |
Why?
| | Animals | 21 | 2026 | 38010 | 0.200 |
Why?
| | Persian Gulf Syndrome | 1 | 2023 | 18 | 0.200 |
Why?
| | Transcription Factor DP1 | 2 | 2023 | 26 | 0.190 |
Why?
| | Irritable Bowel Syndrome | 1 | 2023 | 29 | 0.190 |
Why?
| | Gonadotropin-Releasing Hormone | 4 | 2021 | 213 | 0.190 |
Why?
| | Fertility | 1 | 2024 | 166 | 0.190 |
Why?
| | Pituitary Hormones | 1 | 2022 | 16 | 0.190 |
Why?
| | Estrogens | 4 | 2026 | 372 | 0.190 |
Why?
| | Rats | 10 | 2006 | 5610 | 0.180 |
Why?
| | Transcription Factor Pit-1 | 6 | 2003 | 27 | 0.180 |
Why?
| | Thyrotropin | 1 | 2022 | 116 | 0.180 |
Why?
| | Thyroid Hormones | 1 | 2022 | 68 | 0.180 |
Why?
| | Hypothalamus | 2 | 2014 | 154 | 0.180 |
Why?
| | Transcription, Genetic | 3 | 2009 | 1511 | 0.180 |
Why?
| | Mindfulness | 1 | 2024 | 151 | 0.180 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 3 | 1997 | 258 | 0.170 |
Why?
| | Emulsions | 1 | 2021 | 57 | 0.170 |
Why?
| | Tandem Mass Spectrometry | 2 | 2015 | 566 | 0.170 |
Why?
| | Gastrointestinal Diseases | 1 | 2023 | 211 | 0.170 |
Why?
| | Thinness | 1 | 2021 | 98 | 0.160 |
Why?
| | Heparin | 1 | 2022 | 254 | 0.160 |
Why?
| | Leptin | 1 | 2022 | 239 | 0.160 |
Why?
| | Adult | 18 | 2026 | 40013 | 0.160 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2021 | 158 | 0.160 |
Why?
| | Gastroesophageal Reflux | 1 | 2023 | 244 | 0.160 |
Why?
| | Wnt Proteins | 1 | 2021 | 137 | 0.160 |
Why?
| | Adiponectin | 1 | 2022 | 244 | 0.160 |
Why?
| | Creatinine | 1 | 2022 | 494 | 0.160 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p18 | 2 | 2016 | 16 | 0.160 |
Why?
| | Enzyme Activation | 3 | 2009 | 790 | 0.160 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2012 | 177 | 0.160 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 6 | 2003 | 25 | 0.160 |
Why?
| | Bcl-2-Like Protein 11 | 2 | 2016 | 38 | 0.160 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 318 | 0.160 |
Why?
| | Feasibility Studies | 1 | 2024 | 1051 | 0.150 |
Why?
| | Chitinase-3-Like Protein 1 | 1 | 2019 | 19 | 0.150 |
Why?
| | Lipids | 2 | 2022 | 704 | 0.150 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2019 | 66 | 0.150 |
Why?
| | Cell Cycle | 2 | 2015 | 648 | 0.150 |
Why?
| | Wnt Signaling Pathway | 1 | 2021 | 213 | 0.150 |
Why?
| | beta Catenin | 1 | 2021 | 256 | 0.150 |
Why?
| | Biomarkers | 2 | 2024 | 4241 | 0.150 |
Why?
| | Eicosapentaenoic Acid | 1 | 2019 | 36 | 0.150 |
Why?
| | Cytoskeletal Proteins | 1 | 2019 | 154 | 0.140 |
Why?
| | Follicular Phase | 2 | 2015 | 39 | 0.140 |
Why?
| | Docosahexaenoic Acids | 1 | 2019 | 85 | 0.140 |
Why?
| | Gene Knockdown Techniques | 2 | 2009 | 336 | 0.140 |
Why?
| | Immunoenzyme Techniques | 2 | 2009 | 206 | 0.140 |
Why?
| | Microtubule-Associated Proteins | 1 | 2019 | 201 | 0.140 |
Why?
| | Pituitary Gland, Anterior | 1 | 1997 | 38 | 0.140 |
Why?
| | Etoposide | 2 | 2009 | 165 | 0.130 |
Why?
| | Young Adult | 11 | 2026 | 13972 | 0.130 |
Why?
| | Genes, p16 | 1 | 2016 | 14 | 0.130 |
Why?
| | Aromatase | 2 | 2014 | 31 | 0.130 |
Why?
| | Pregnancy | 4 | 2024 | 7153 | 0.130 |
Why?
| | Oncogene Proteins | 1 | 1996 | 65 | 0.120 |
Why?
| | Fibroblasts | 3 | 2018 | 1044 | 0.120 |
Why?
| | Genes, ras | 2 | 1997 | 94 | 0.120 |
Why?
| | Mice, Nude | 2 | 2025 | 710 | 0.120 |
Why?
| | Stress, Psychological | 1 | 2024 | 1134 | 0.120 |
Why?
| | Blotting, Western | 2 | 2009 | 1223 | 0.120 |
Why?
| | Ovulation | 1 | 2015 | 40 | 0.120 |
Why?
| | Cumulus Cells | 1 | 2015 | 6 | 0.110 |
Why?
| | Molecular Sequence Annotation | 1 | 2015 | 101 | 0.110 |
Why?
| | Dietary Supplements | 2 | 2019 | 587 | 0.110 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 464 | 0.110 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1504 | 0.110 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2023 | 871 | 0.110 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2015 | 188 | 0.110 |
Why?
| | Tumor Suppressor Protein p14ARF | 1 | 2014 | 7 | 0.110 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 374 | 0.110 |
Why?
| | Transcription Factors, TFII | 2 | 2024 | 44 | 0.110 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 1984 | 0.110 |
Why?
| | Blood Chemical Analysis | 1 | 2015 | 110 | 0.110 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2015 | 142 | 0.110 |
Why?
| | Hormone Antagonists | 1 | 2014 | 34 | 0.110 |
Why?
| | Luteal Phase | 1 | 2014 | 46 | 0.100 |
Why?
| | Hypogonadism | 3 | 2024 | 92 | 0.100 |
Why?
| | Transfection | 3 | 2009 | 949 | 0.100 |
Why?
| | Repressor Proteins | 1 | 1997 | 438 | 0.100 |
Why?
| | Neoplasms, Experimental | 1 | 2014 | 174 | 0.100 |
Why?
| | Circadian Rhythm | 1 | 2017 | 513 | 0.100 |
Why?
| | RNA Interference | 2 | 2018 | 474 | 0.100 |
Why?
| | Culture Media, Serum-Free | 2 | 2003 | 45 | 0.100 |
Why?
| | Postmenopause | 1 | 2015 | 377 | 0.090 |
Why?
| | DNA Fingerprinting | 1 | 2012 | 29 | 0.090 |
Why?
| | Base Sequence | 3 | 2012 | 2199 | 0.090 |
Why?
| | RNA, Small Interfering | 2 | 2018 | 637 | 0.090 |
Why?
| | Exercise | 1 | 2024 | 2151 | 0.090 |
Why?
| | Cell Line | 5 | 2018 | 2897 | 0.090 |
Why?
| | DNA, Complementary | 2 | 2012 | 277 | 0.090 |
Why?
| | Breast Neoplasms | 3 | 2012 | 2318 | 0.090 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 330 | 0.090 |
Why?
| | Mice | 6 | 2026 | 18378 | 0.090 |
Why?
| | Body Mass Index | 4 | 2026 | 2429 | 0.080 |
Why?
| | Pulsatile Flow | 1 | 2011 | 55 | 0.080 |
Why?
| | Veterans | 1 | 2023 | 1544 | 0.080 |
Why?
| | Testosterone | 1 | 2015 | 423 | 0.080 |
Why?
| | NF-kappa B | 2 | 2025 | 685 | 0.080 |
Why?
| | Cell Survival | 2 | 2021 | 1136 | 0.080 |
Why?
| | Protein Isoforms | 2 | 2003 | 404 | 0.080 |
Why?
| | Pituitary Neoplasms | 2 | 2003 | 195 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 994 | 0.080 |
Why?
| | Adiposity | 1 | 2015 | 532 | 0.080 |
Why?
| | Colony-Forming Units Assay | 1 | 2009 | 94 | 0.080 |
Why?
| | Mutation | 1 | 2021 | 4053 | 0.080 |
Why?
| | Infertility, Female | 2 | 2024 | 110 | 0.080 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 79 | 0.080 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2009 | 74 | 0.080 |
Why?
| | Luciferases | 1 | 2009 | 152 | 0.080 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2009 | 82 | 0.080 |
Why?
| | Transforming Growth Factor beta | 1 | 2012 | 484 | 0.080 |
Why?
| | Progesterone | 3 | 2016 | 258 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2015 | 763 | 0.080 |
Why?
| | Cyclin D1 | 1 | 2009 | 74 | 0.070 |
Why?
| | Mutant Proteins | 1 | 2009 | 104 | 0.070 |
Why?
| | Inflammation | 2 | 2024 | 2881 | 0.070 |
Why?
| | NIH 3T3 Cells | 1 | 2009 | 150 | 0.070 |
Why?
| | Models, Biological | 2 | 2016 | 1831 | 0.070 |
Why?
| | Matrix Metalloproteinase 11 | 1 | 2008 | 4 | 0.070 |
Why?
| | Membrane Proteins | 1 | 2015 | 1171 | 0.070 |
Why?
| | PTEN Phosphohydrolase | 1 | 2009 | 165 | 0.070 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2012 | 549 | 0.070 |
Why?
| | RNA, Neoplasm | 1 | 2008 | 83 | 0.070 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 273 | 0.070 |
Why?
| | Myometrium | 1 | 2008 | 39 | 0.070 |
Why?
| | Neoplastic Stem Cells | 1 | 2012 | 414 | 0.070 |
Why?
| | Rabbits | 1 | 2009 | 665 | 0.070 |
Why?
| | DNA, Neoplasm | 1 | 2008 | 162 | 0.070 |
Why?
| | Cell Adhesion | 1 | 2009 | 456 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2024 | 1671 | 0.070 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 518 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2009 | 441 | 0.070 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2007 | 123 | 0.070 |
Why?
| | DNA Primers | 1 | 2008 | 518 | 0.070 |
Why?
| | Subcellular Fractions | 1 | 2006 | 76 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-raf | 2 | 1997 | 44 | 0.060 |
Why?
| | HeLa Cells | 2 | 2000 | 650 | 0.060 |
Why?
| | Mammary Glands, Human | 1 | 2007 | 67 | 0.060 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2016 | 90 | 0.060 |
Why?
| | Immunoprecipitation | 1 | 2006 | 153 | 0.060 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2006 | 99 | 0.060 |
Why?
| | Pregnanediol | 1 | 2026 | 20 | 0.060 |
Why?
| | Growth Hormone-Releasing Hormone | 1 | 2006 | 25 | 0.060 |
Why?
| | raf Kinases | 1 | 2006 | 12 | 0.060 |
Why?
| | Ultraviolet Rays | 1 | 2009 | 401 | 0.060 |
Why?
| | Autocrine Communication | 1 | 2006 | 40 | 0.060 |
Why?
| | DNA Damage | 1 | 2009 | 446 | 0.060 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1997 | 167 | 0.060 |
Why?
| | Receptors, Growth Factor | 1 | 2006 | 56 | 0.060 |
Why?
| | Prostate | 1 | 2007 | 173 | 0.060 |
Why?
| | Paracrine Communication | 1 | 2006 | 67 | 0.060 |
Why?
| | Caspases | 1 | 2006 | 246 | 0.060 |
Why?
| | Middle Aged | 3 | 2024 | 35342 | 0.060 |
Why?
| | Reproduction | 1 | 2007 | 206 | 0.060 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2006 | 196 | 0.060 |
Why?
| | Protein Kinase Inhibitors | 2 | 2009 | 963 | 0.060 |
Why?
| | ras Proteins | 1 | 2006 | 146 | 0.060 |
Why?
| | Hypothalamo-Hypophyseal System | 2 | 2017 | 198 | 0.060 |
Why?
| | Protein Binding | 2 | 2024 | 2261 | 0.060 |
Why?
| | Prospective Studies | 4 | 2023 | 7899 | 0.060 |
Why?
| | Adolescent | 7 | 2021 | 22481 | 0.050 |
Why?
| | Oncogene Protein p65(gag-jun) | 1 | 2004 | 2 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2006 | 302 | 0.050 |
Why?
| | Pituitary Hormones, Anterior | 1 | 2024 | 7 | 0.050 |
Why?
| | Ideal Body Weight | 1 | 2024 | 4 | 0.050 |
Why?
| | Cyclin D2 | 1 | 2024 | 5 | 0.050 |
Why?
| | Cell Movement | 1 | 2009 | 973 | 0.050 |
Why?
| | Ovulation Induction | 2 | 2015 | 56 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2004 | 56 | 0.050 |
Why?
| | Cell Nucleus | 1 | 2007 | 612 | 0.050 |
Why?
| | Jurkat Cells | 1 | 2024 | 118 | 0.050 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2024 | 80 | 0.050 |
Why?
| | Cyclin-Dependent Kinase 2 | 1 | 2024 | 51 | 0.050 |
Why?
| | Diet, Fat-Restricted | 1 | 2024 | 77 | 0.050 |
Why?
| | Pregnancy Rate | 1 | 2024 | 68 | 0.050 |
Why?
| | Phospholipid Ethers | 1 | 2003 | 4 | 0.050 |
Why?
| | Thiocarbamates | 1 | 2003 | 6 | 0.050 |
Why?
| | Gene Expression | 2 | 2021 | 1505 | 0.050 |
Why?
| | Thiones | 1 | 2003 | 14 | 0.050 |
Why?
| | Norbornanes | 1 | 2003 | 15 | 0.050 |
Why?
| | Chromones | 1 | 2003 | 44 | 0.050 |
Why?
| | Bridged-Ring Compounds | 1 | 2003 | 27 | 0.050 |
Why?
| | E2F3 Transcription Factor | 1 | 2023 | 10 | 0.050 |
Why?
| | Follicle Stimulating Hormone, Human | 1 | 2023 | 12 | 0.050 |
Why?
| | Culturally Competent Care | 1 | 2024 | 69 | 0.050 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1736 | 0.050 |
Why?
| | Gulf War | 1 | 2023 | 15 | 0.050 |
Why?
| | Androstadienes | 1 | 2003 | 74 | 0.050 |
Why?
| | Abortion, Spontaneous | 1 | 2024 | 117 | 0.050 |
Why?
| | Cell Death | 1 | 2024 | 394 | 0.050 |
Why?
| | Thyroid Neoplasms | 1 | 2007 | 337 | 0.050 |
Why?
| | Protein Domains | 1 | 2024 | 308 | 0.050 |
Why?
| | Morpholines | 1 | 2003 | 129 | 0.050 |
Why?
| | Molecular Sequence Data | 4 | 2012 | 2942 | 0.050 |
Why?
| | Cluster Analysis | 2 | 2015 | 526 | 0.050 |
Why?
| | Acetophenones | 1 | 2001 | 13 | 0.040 |
Why?
| | Models, Molecular | 1 | 2007 | 1622 | 0.040 |
Why?
| | Benzopyrans | 1 | 2001 | 30 | 0.040 |
Why?
| | Carbazoles | 1 | 2001 | 57 | 0.040 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 2021 | 39 | 0.040 |
Why?
| | Naphthalenes | 1 | 2001 | 60 | 0.040 |
Why?
| | Transcription Factor CHOP | 1 | 2021 | 32 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2024 | 510 | 0.040 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2021 | 29 | 0.040 |
Why?
| | Focus Groups | 1 | 2024 | 570 | 0.040 |
Why?
| | Immunoblotting | 1 | 2001 | 313 | 0.040 |
Why?
| | Indazoles | 1 | 2021 | 78 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2004 | 382 | 0.040 |
Why?
| | Adenoviridae | 1 | 2001 | 204 | 0.040 |
Why?
| | Self Efficacy | 1 | 2024 | 409 | 0.040 |
Why?
| | Genetic Fitness | 1 | 2021 | 59 | 0.040 |
Why?
| | Glucose Clamp Technique | 1 | 2021 | 198 | 0.040 |
Why?
| | Heat-Shock Proteins | 1 | 2021 | 140 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2021 | 124 | 0.040 |
Why?
| | Imidazoles | 1 | 2021 | 252 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2021 | 354 | 0.040 |
Why?
| | DNA | 2 | 1997 | 1457 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 686 | 0.040 |
Why?
| | Aged | 1 | 2019 | 25322 | 0.040 |
Why?
| | Histones | 1 | 2024 | 666 | 0.040 |
Why?
| | ADP-Ribosylation Factors | 1 | 2018 | 18 | 0.040 |
Why?
| | Pancreatic Neoplasms | 1 | 2007 | 924 | 0.040 |
Why?
| | Progestins | 1 | 2019 | 85 | 0.040 |
Why?
| | Self Report | 1 | 2023 | 877 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2024 | 688 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2006 | 2020 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2021 | 431 | 0.030 |
Why?
| | Dimerization | 1 | 2018 | 197 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2021 | 535 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2001 | 839 | 0.030 |
Why?
| | Recurrence | 1 | 2021 | 1114 | 0.030 |
Why?
| | Indoles | 1 | 2001 | 479 | 0.030 |
Why?
| | Proto-Oncogene Protein c-ets-2 | 1 | 1997 | 4 | 0.030 |
Why?
| | Ectopic Gene Expression | 1 | 2016 | 5 | 0.030 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 1996 | 12 | 0.030 |
Why?
| | Pyridines | 1 | 2021 | 593 | 0.030 |
Why?
| | Disease Management | 1 | 2021 | 646 | 0.030 |
Why?
| | Catalysis | 1 | 1997 | 322 | 0.030 |
Why?
| | Pituitary-Adrenal System | 1 | 2017 | 165 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 1996 | 135 | 0.030 |
Why?
| | Hormones | 1 | 2016 | 138 | 0.030 |
Why?
| | Administration, Cutaneous | 1 | 2015 | 129 | 0.030 |
Why?
| | Oocyte Retrieval | 1 | 2015 | 12 | 0.030 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2015 | 65 | 0.030 |
Why?
| | Neovascularization, Physiologic | 1 | 2016 | 186 | 0.030 |
Why?
| | Limit of Detection | 1 | 2015 | 95 | 0.030 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2014 | 7 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2015 | 272 | 0.030 |
Why?
| | Protein-Tyrosine Kinases | 1 | 1997 | 430 | 0.030 |
Why?
| | Trans-Activators | 1 | 1997 | 402 | 0.030 |
Why?
| | Binding Sites | 1 | 1997 | 1325 | 0.030 |
Why?
| | Cellular Microenvironment | 1 | 2015 | 92 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 1997 | 677 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 346 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1995 | 517 | 0.030 |
Why?
| | Ovary | 1 | 2015 | 227 | 0.030 |
Why?
| | Anions | 1 | 2013 | 31 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2015 | 392 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2013 | 147 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2015 | 453 | 0.020 |
Why?
| | Fatty Acids | 1 | 2015 | 452 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2012 | 157 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2024 | 2113 | 0.020 |
Why?
| | Genetic Therapy | 1 | 2014 | 319 | 0.020 |
Why?
| | Heterografts | 1 | 2012 | 138 | 0.020 |
Why?
| | Gene Library | 1 | 2012 | 123 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1226 | 0.020 |
Why?
| | Protein Kinases | 1 | 1992 | 310 | 0.020 |
Why?
| | Nitriles | 1 | 2011 | 193 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 894 | 0.020 |
Why?
| | Triazoles | 1 | 2011 | 168 | 0.020 |
Why?
| | Male | 4 | 2017 | 71500 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2011 | 773 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 11365 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2012 | 823 | 0.020 |
Why?
| | Receptors, Pituitary Hormone-Regulating Hormone | 1 | 2006 | 8 | 0.020 |
Why?
| | Receptors, Neuropeptide | 1 | 2006 | 12 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2017 | 5743 | 0.010 |
Why?
| | Transcriptome | 1 | 2012 | 1029 | 0.010 |
Why?
| | Prognosis | 1 | 2012 | 4152 | 0.010 |
Why?
| | Liver | 1 | 1992 | 1864 | 0.010 |
Why?
| | Suppression, Genetic | 1 | 2003 | 24 | 0.010 |
Why?
| | Genes, Dominant | 1 | 2003 | 97 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2004 | 342 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2012 | 4522 | 0.010 |
Why?
| | Amino Acid Sequence | 2 | 1997 | 2165 | 0.010 |
Why?
| | Phosphothreonine | 1 | 1997 | 6 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1997 | 397 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1997 | 367 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 1997 | 576 | 0.010 |
Why?
| | Drosophila Proteins | 1 | 1997 | 208 | 0.010 |
Why?
| | Nerve Tissue Proteins | 1 | 1997 | 607 | 0.010 |
Why?
| | Biological Evolution | 1 | 1997 | 493 | 0.010 |
Why?
| | Chromatography, Ion Exchange | 1 | 1992 | 53 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 1992 | 129 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1992 | 332 | 0.010 |
Why?
| | Molecular Weight | 1 | 1992 | 327 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 334 | 0.010 |
Why?
| | Cytosol | 1 | 1992 | 225 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1992 | 383 | 0.010 |
Why?
| | Peptides | 1 | 1997 | 976 | 0.010 |
Why?
| | Oligopeptides | 1 | 1992 | 266 | 0.010 |
Why?
| | Cells, Cultured | 1 | 1997 | 4182 | 0.000 |
Why?
| | Kinetics | 1 | 1992 | 1628 | 0.000 |
Why?
|
|
Bradford's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|